All In MedTech

Device Trial Radar · NCT05336877

Aveir VR Coverage With Evidence Development Post-Approval Study

Aveir Single-Chamber Leadless Pacemaker Coverage With Evidence Development (ACED) Post-Approval Study

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

8,744

Planned (sponsor's estimate)

Start

Jun 21, 2022

Primary completion

Jan 1, 2028

Study completion Jan 1, 2028

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Apr 20, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).

Conditions

  • Cardiac Pacemaker
  • Arrythmia
  • Bradycardia

Interventions

  • Aveir VR Leadless Pacemaker SystemDevice

    This study will utilize real-world data from patients implanted with the Aveir VR Leadless Pacemaker System. No device intervention is required in this study.

  • Single-Chamber Transvenous PacemakerDevice

    This study will utilize real-world data from patients implanted with a single-chamber transvenous pacemaker as a comparator to the Aveir VR LP system study arm. No device intervention is required in this study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects with Acute Device-Related ComplicationsTime frame: 30 days
  2. Number of Subjects Alive after 2 YearsTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Abbott

    Sylmar, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.